The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in Patients with Multiple Myeloma (MM).
Ho M, Zanwar S, Kapoor P, Gertz M, Lacy M, Dispenzieri A, Hayman S, Dingli D, Baudi F, Muchtar E, Leung N, Kourelis T, Warsame R, Fonder A, Hwa L, Hobbs M, Kyle R, Rajkumar SV, Kumar S..
.
. Kanji JN, et al.Vaccine. 2021 Sep 15;39(39):5563-5570. doi: 10.1016/j.vaccine.2021.08.022. Epub 2021 Aug 11.Vaccine. 2021.PMID: 34454782. Waldschmidt JM, et al.Clin Cancer Res. 2021 Sep 13:clincanres.2040.2021. doi: 10.1158/1078-0432.CCR-21-2040. Online ahead of print.Clin Cancer Res. 2021.PMID: 34518309. Zhang L, et al.J Dermatol. 2021 Sep 6. doi: 10.1111/1346-8138.16126. Online ahead of print.J Dermatol. 2021.PMID: 34487567
![top](data:image/svg+xml,%3Csvg%20xmlns="http://www.w3.org/2000/svg"%20width="16"%20height="16"%3E%3Crect%20fill-opacity="0"/%3E%3C/svg%3E "top")